Clermont-Ferrand, 14 February 2019 – (FR0004177046 METEX), FR0004177046 METEX), METabolic EXplorer (METEX), an industrial biochemical company specialising in the development and industrial application of green and sustainable fermentation processes, today published its financial data for fourth-quarter 2018.
In fourth-quarter 2018, METabolic EXplorer posted net sales of €457,000. This amount consists in revenues from a technology transfer service agreement with Evonik, for 2 years, on the sale of L-methionine/inoLa™ technology in November 2016.
At end-December, the company thus posted annual turnover of €3.308 million.
At 31 December 2018, the company’s gross cash position under IFRS standards stood at €35.5 million, compared with €31.3 million at 31 December 2017. This includes the cash position of its subsidiary METEX NØØVISTA amounting to €12 million following the capital increase carried out in December 2018, with a contribution of €6 million from METEX and €6 million from the Bpifrance investment fund Société de Projets Industriels (SPI).
Gross debt amounted to €6.7 million, compared with €6.1 million at end-2017. The reasons for this slight increase are the following:
– the repayment of the balance of the advance received from Bpifrance in 2015 in relation to promoting methionine for an amount of €750,000;
– a short-term loan to finance the equipment for its industrial demonstrator and its R&D laboratories for an amount of €460,000.
These amounts were collected in December 2018, thus increasing the cash position of the company by €1.21 million. METEX notes that its subsidiary METEX NØØVISTA had no debt at 31 December 2018.
About METabolic EXplorer – www.metabolic-explorer.com
A pioneer in industrial biochemistry with some 20 years of experience, METabolic Explorer (METEX) develops alternative solutions to the petrochemical processes used in manufacturing.
Using renewable raw materials, it develops innovative industrial fermentation processes to produce competitive chemical compounds used in basic products of everyday life such as animal nutrition and health additives, plastics, textiles, cosmetics, and resins, among many others.
The company’s ambition with its biotechnological innovations is to produce consumer goods in a different way, without oil, in order to meet consumers’ new societal expectations and the objectives of the energy transition and sustainable development.
To create these innovative processes, METabolic EXplorer relies on a 70-person staff possessing the complementary competencies essential at every step of their development, from the optimization of biochemical catalysts in the laboratory to the industrial validation and production of samples in an industrial demonstration unit in continuous operation.
Based at the Clermont Limagne technology park, near Clermont-Ferrand, METabolic Explorer is listed on Euronext in Paris (Compartment C, METEX) and is included in the CAC Small Index.
Get free financial information on METabolic EXplorer by registering with:
Investor relations – ACTIFIN –
Tél : + 33 (0) 1 56 88 11 11
mail : email@example.com
Media relations – ACTIFIN –
Tél : + 33 (0) 1 56 88 11 11
mail : firstname.lastname@example.org